Northeast Financial Consultants’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Northeast Financial Consultants’s Portfolio KNSA Stock Details KNSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10,130	Closed	-$101K	–	364
2022 Q1	$101K	Sell	10,130 -1,310	-11%	-$13.9K	0.01%	379
2021 Q4	$135K	Hold	11,440	–	–	0.01%	345
2021 Q3	$130K	Buy	+11,440	New	+$149K	0.01%	344
2020 Q3	–	Sell	-8,290	Closed	-$210K	–	307
2020 Q2	$210K	Buy	+8,290	New	+$173K	0.02%	264

Other funds holding KNSA

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Hudson Bay Capital Management

Hudson Bay Capital Management Stamford, Connecticut $16.6B AUM 30.2% 1-Year Est. Return

Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return